| 发明名称 |
Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate |
| 摘要 |
This invention relates to novel amorphous and crystallline forms of 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt, useful as inhibitors of protein kinases, and to their methods of preparation.
|
| 申请公布号 |
US6965027(B2) |
申请公布日期 |
2005.11.15 |
| 申请号 |
US20020310078 |
申请日期 |
2002.12.04 |
| 申请人 |
PFIZER INC. |
发明人 |
FLANAGAN MARK E.;LI ZHENG J. |
| 分类号 |
A61K31/519;A61K45/00;A61P1/04;A61P3/10;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P25/00;A61P25/28;A61P29/00;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D487/04;(IPC1-7):C07D401/12 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
